Skip to main content
. 2020 Apr 21;21(8):2900. doi: 10.3390/ijms21082900

Figure 2.

Figure 2

Experimental design. Groups included were 1) AD-Con fed 45% fat diet with 0.5% dextrin in Alzheimer’s disease (AD) rats having the intra-CA1 infusion of amyloid-β(25–35), 2) AD-TTK fed 45% fat diet with 0.5% water extract of Tetragonia tetragonioides (TTK) in AD rats, and 3) Normal-Con fed 45% fat diet with 0.5% dextrin in non-AD rats having the intra-CA1 infusion of amyloid-β(35–25).